Arbutus Biopharma Corp: cash and cash equivalents

What this measure means

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2008-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.

Coverage by original unit

• CAD: 2008-12-31 to 2013-12-31. This unit’s selected history ends more than two years before capture.
• USD: 2010-12-31 to 2025-12-31.

These are separate reported series. A newer period in one unit does not update another unit’s history or establish a currency conversion.

Selected filing history

Related financial histories

• Arbutus Biopharma Corp: total assets
• Arbutus Biopharma Corp: total liabilities
• Arbutus Biopharma Corp: stockholders equity
• Arbutus Biopharma Corp: net income or loss
• Arbutus Biopharma Corp: operating cash flow
• Arbutus Biopharma Corp: capital expenditure payments
• Arbutus Biopharma Corp: revenue
• Arbutus Biopharma Corp: financing cash flow
• Arbutus Biopharma Corp: investing cash flow
• Arbutus Biopharma Corp: retained earnings or deficit
• Arbutus Biopharma Corp: basic weighted-average shares
• Arbutus Biopharma Corp: diluted weighted-average shares
• Arbutus Biopharma Corp: basic earnings per share
• Arbutus Biopharma Corp: diluted earnings per share
• Arbutus Biopharma Corp: income tax expense or benefit
• Arbutus Biopharma Corp: net property, plant and equipment
• Arbutus Biopharma Corp: share-based compensation expense
• Arbutus Biopharma Corp: operating income or loss
• Arbutus Biopharma Corp: current assets
• Arbutus Biopharma Corp: interest expense
• Arbutus Biopharma Corp: current liabilities
• Arbutus Biopharma Corp: goodwill carrying amount
• Arbutus Biopharma Corp: net current accounts receivable
• Arbutus Biopharma Corp: operating expenses
• Arbutus Biopharma Corp: research and development expense

Inspect the source

Entity

Arbutus Biopharma Corp / CIK 0001447028

Captured

2026-09-20T09:04:49.017Z

SEC response SHA-256

d0c406f420689ef604e97fe778a55d59191ec33b490a85e5747539352bb315a4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001447028.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))